- Report
- March 2024
- 195 Pages
Global
From €3208EUR$3,374USD£2,751GBP
€3564EUR$3,749USD£3,057GBP
- Report
- July 2023
- 150 Pages
Global
From €5656EUR$5,950USD£4,852GBP
- Report
- February 2024
- 175 Pages
Global
From €4753EUR$5,000USD£4,077GBP
- Report
- November 2023
- 190 Pages
Global
From €4658EUR$4,900USD£3,996GBP
- Report
- November 2022
- 78 Pages
United States
From €5656EUR$5,950USD£4,852GBP
- Report
- May 2021
- 120 Pages
Global
From €4516EUR$4,750USD£3,873GBP
- Report
- August 2022
- 150 Pages
Global
From €4516EUR$4,750USD£3,873GBP
Biopharmaceutical Third Party Logistics (3PL) is a specialized form of logistics services that focuses on the storage, transportation, and distribution of biopharmaceutical products. These products are typically temperature-sensitive and require specialized handling and storage conditions. 3PL providers offer a range of services, including temperature-controlled storage, order fulfillment, and distribution. They also provide value-added services such as inventory management, packaging, and labeling.
3PL providers are an important part of the biopharmaceutical supply chain, as they help ensure that products are delivered safely and on time. They also help reduce costs and improve efficiency by providing a range of services that are tailored to the needs of the biopharmaceutical industry.
Some of the leading companies in the biopharmaceutical 3PL market include AmerisourceBergen, Cardinal Health, McKesson, FedEx, UPS, and DHL. Show Less Read more